Skip Navigation

JNCI Journal of the National Cancer Institute 2004 96(11):817; doi:10.1093/jnci/96.11.817
© 2004 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Tuma, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tuma, R. S.
Related Collections
Right arrowRelated News Article in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Oxford University Press

NEWS

Proteomics: From Signature to Protein Identification

Rabiya S. Tuma

The first 10% of the full text of this article appears below.

A proteomics technique for diagnosing early-stage ovarian cancer developed 2 years ago by researchers at the U.S. Food and Drug Administration and the National Cancer Institute relied solely on the pattern generated by mass spectrometry analysis to distinguish between serum samples from healthy women and those with ovarian . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related News Article in JNCI

Debate Rages Over Proteomic Patterns
Ken Garber
J Natl Cancer Inst 2004 96: 816-818. [Extract] [Full Text] [PDF]